ATH 33.3% 0.4¢ alterity therapeutics limited

The "AMR" action fund Invested 41M in Adaptive Phage Therapeutics, page-4

  1. 2,840 Posts.
    lightbulb Created with Sketch. 995
    I understood the 41M in a wrong way, the Fund only joined an existing $41 million Series B round as a co-investor. Sorry for that.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.